NVAX Jan 2025 22.500 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:31AM EDT. Market open.
| Previous close | 6.50 |
| Open | 6.50 |
| Bid | 8.60 |
| Ask | 9.10 |
| Strike | 22.50 |
| Expiry date | 2025-01-17 |
| Day's range | 6.50 - 6.50 |
| Contract range | N/A |
| Volume | |
| Open interest | 61 |
Yahoo FinanceNovavax's stock surges almost 300% in the past month
Novavax stock is soaring on news the FDA set a deadline by which to approve or reject its COVID-19 vaccine.
Investor's Business DailyNovavax, With A 369% Gain, Reverses Bullish Gains After Key FDA Move
Novavax stock zipped higher and then plunged Thursday after the FDA set a potential approval date for its Covid vaccine in April.
Barrons.comNew Covid Boosters Get a Thumbs-Up From FDA. Vaccine Stocks Are Wavering.
Drugmakers are aiming to launch this year’s shots by the beginning of September but have been waiting on the FDA to decide which strain of the virus to target. At their meeting on Wednesday, the FDA’s advisers nevertheless recommended that this year’s shots target JN.1, saying they expect a JN.1 shot to offer sufficient protection against the strain’s descendants.
© 2024 Yahoo. All rights reserved.